These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 16463554)
1. [What drug protect from dementia?]. Ziegler R Med Monatsschr Pharm; 2006 Jan; 29(1):37-8. PubMed ID: 16463554 [No Abstract] [Full Text] [Related]
2. More promotional rhetoric in research: the Maryland Assisted Living Study. Finucane TE J Am Geriatr Soc; 2008 Jan; 56(1):185; author reply 1185-6. PubMed ID: 18184223 [No Abstract] [Full Text] [Related]
3. NSAIDs in the prevention of dementia: a Cache-22? Scharf JM; Daffner KR Neurology; 2007 Jul; 69(3):235-6. PubMed ID: 17636059 [No Abstract] [Full Text] [Related]
4. Prevention of Alzheimer's disease and dementia. Major findings from the Kungsholmen Project. Fratiglioni L; Winblad B; von Strauss E Physiol Behav; 2007 Sep; 92(1-2):98-104. PubMed ID: 17588621 [TBL] [Abstract][Full Text] [Related]
5. Current issues in dementia pharmacotherapy. Daiello LA Am J Manag Care; 2007 Dec; 13 Suppl 8():S198-202. PubMed ID: 18095783 [TBL] [Abstract][Full Text] [Related]
6. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
7. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Expert Consensus Panel for Dementia Postgrad Med; 2005 Jan; Spec No():1-111. PubMed ID: 17203560 [No Abstract] [Full Text] [Related]
8. [Alzheimer's disease: from brain lesions to new drugs]. Forette F; Hauw JJ Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689 [TBL] [Abstract][Full Text] [Related]
9. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary. Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561 [TBL] [Abstract][Full Text] [Related]
10. [Anti-inflammatory drug therapy for prevention of Alzheimer's Disease?]. Sulkava R Duodecim; 1998; 114(20):2025, 2027. PubMed ID: 11717722 [No Abstract] [Full Text] [Related]
11. Alzheimer therapeutics-what after the cholinesterase inhibitors? Walker LC; Rosen RF Age Ageing; 2006 Jul; 35(4):332-5. PubMed ID: 16644763 [No Abstract] [Full Text] [Related]
12. [Treatment of degenerative dementia disorders--who should be treated?]. Hasselbalch SG; Kampmann JP Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606 [TBL] [Abstract][Full Text] [Related]
13. Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis. Zhou B; Teramukai S; Fukushima M Dement Geriatr Cogn Disord; 2007; 23(3):194-201. PubMed ID: 17259710 [TBL] [Abstract][Full Text] [Related]
14. Cognitive frailty: a potential target for secondary prevention of dementia. Panza F; Lozupone M; Solfrizzi V; Stallone R; Bellomo A; Greco A; Daniele A; Seripa D; Logroscino G Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1023-1027. PubMed ID: 28849681 [No Abstract] [Full Text] [Related]
16. Adverse events in patients receiving cholinesterase inhibitors due to dissimilar follow-up periods. Chan M Arch Intern Med; 2009 Oct; 169(18):1724; author reply 1724-5. PubMed ID: 19822833 [No Abstract] [Full Text] [Related]
17. [A reply to Pfizer: Still no reason to change SBU's conclusions on drugs against dementia]. Edhag O; Norlund A Lakartidningen; 2007 Jan 10-16; 104(1-2):55. PubMed ID: 17323745 [No Abstract] [Full Text] [Related]
18. Drugs for cognitive loss and dementia. Treat Guidel Med Lett; 2007 Feb; 5(54):9-14. PubMed ID: 17261969 [No Abstract] [Full Text] [Related]